Publicaciones (184) Publicaciones de Juan Pablo de Torres Tajes

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

  3. Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

    Archivos de Bronconeumologia

  4. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100

  5. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

  6. Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma

    eBioMedicine, Vol. 102

2023

  1. Continuous Monitoring of Pulse Oximetry During the 6-Minute Walk Test Improves Clinical Outcomes Prediction in COPD

    Respiratory care, Vol. 68, Núm. 1, pp. 92-100

  2. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease

    Annals of the American Thoracic Society, Vol. 20, Núm. 10, pp. 1425-1434

  3. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

  4. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  5. Neurophysiological mechanisms of exertional dyspnea in post-pulmonary embolism syndrome

    Journal of applied physiology (Bethesda, Md. : 1985), Vol. 134, Núm. 3, pp. 667-677

  6. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease

    Respiratory Physiology and Neurobiology, Vol. 312

  7. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO

    Respiratory care, Vol. 68, Núm. 12, pp. 1662-1674

  8. “Another Hole in the Wall”: The Importance of Centrilobular Emphysema in Patients With COPD

    Chest

2022

  1. COPD detection in lung cancer screening programmes: “hitting two birds with one stone”

    European Respiratory Journal

  2. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort

    Respirology, Vol. 27, Núm. 4, pp. 286-293

  3. Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease

    Respiratory Research, Vol. 23, Núm. 1

  4. Emphysema: the risk of cancer and the impact on cancer care

    ERS Monograph, Vol. 2022, Núm. 98, pp. 105-117

  5. Exertional dyspnoea in patients with mild-to-severe chronic obstructive pulmonary disease: neuromechanical mechanisms

    Journal of Physiology, Vol. 600, Núm. 18, pp. 4227-4245

  6. Impaired Ventilatory Efficiency, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease Results from the CanCOLD Study

    American Journal of Respiratory and Critical Care Medicine, Vol. 205, Núm. 12, pp. 1391-1402